I agree that this site is using cookies. You can find further informations here.
X
Bahroo, L.
27  results:
Search for persons X
?
1

Onset of action for rimabotulinumtoxinB in the treatment of..:

Bahroo, L. ; Lew, M. ; Pahwa, R....
Parkinsonism & Related Disorders.  79 (2020)  - p. e56 , 2020
Link: https://doi.org/10.1016/..
 
?
2

Current ICD-10-CM coding does not adequately reflect Parkin..:

Dashtipour, K. ; Bahroo, L. ; Pagan, F...
Parkinsonism & Related Disorders.  79 (2020)  - p. e80 , 2020
Link: https://doi.org/10.1016/..
 
?
3

PND84 - PATIENT AND CAREGIVER BURDEN OF BOTULINUM TOXIN A I..:

Fernandez, M ; Bahroo, L ; Lundkvist, J...
Value in Health.  21 (2018)  - p. S343 , 2018
Link: https://doi.org/10.1016/..
 
?
4

Impact of spasticity and botulinum toxin-A injections on th..:

Bahroo, L. ; Balcaitiene, J. ; Fernandez, M. Murie...
Annals of Physical and Rehabilitation Medicine.  61 (2018)  - p. e358 , 2018
Link: https://doi.org/10.1016/..
 
?
5

AbobotulinumtoxinA provides flexibility for the treatment o..:

Lew, Mark F. ; Hauser, Robert A. ; Isaacson, Stuart H....
Clinical Parkinsonism & Related Disorders.  5 (2021)  - p. 100115 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Onset of Action for RimabotulinumtoxinB in the Treatment of..:

Bahroo, Laxman ; Isaacson, Stuart ; Pahwa, Rajesh..
Neurology.  94 (2020)  15_supplement - p. , 2020
Link: https://doi.org/10.1212/..
 
?
7

AbobotulinumtoxinA using 2-mL dilution (500 U/2-mL) maintai..:

Dashtipour, Khashayar ; Wietek, Stefan ; Rubin, Bruce...
Journal of Clinical Movement Disorders.  7 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
8

Keeping up with the clinical advances: tardive dyskinesia:

Elkurd, Mazen T. ; Bahroo, Laxman
CNS Spectrums.  24 (2019)  S1 - p. 70-81 , 2019
Link: https://doi.org/10.1017/..
 
?
9

The Trend in Botulinum Toxin Injection among Medicare Neuro..:

Miri, Shahnaz ; Bahroo, Laxman
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
10

Burden of Spasticity Among Patients and Caregivers: Results..:

Patel, Atul ; Wein, Theodore ; Bahroo, Laxman...
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
11

Pseudobulbar Affect in Parkinsonian Syndromes (P3.8-016):

Elkurd, Mazen ; Mohammadi, Cameron ; Torres-Yaghi, Yasar...
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
12

AbobotulinumtoxinA using 2 mL dilution maintains durable fu..:

Dashtipour, Khashayar ; Bahroo, Laxman ; Truong, Daniel...
Toxicon.  156 (2018)  - p. S19-S20 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Poster 27 Analyzing the Patient Journey for Patients Living..:

Bowers, David ; Khan, Patricia ; Dashtipour, Khashayar...
PM&R.  7 (2015)  9S - p. , 2015
Link: https://doi.org/10.1016/..
 
?
14

126. BoNT/A immunogenicity: a systematic review of the lite..:

Lacroix-Desmazes, Sébastien ; Colosimo, Carlo ; Bahroo, Laxman..
Toxicon.  93 (2015)  - p. S39 , 2015
Link: https://doi.org/10.1016/..
 
?
15

An Update on the Use of Botulinum Toxin Therapy in Parkinso..:

Mills, Reversa ; Bahroo, Laxman ; Pagan, Fernando
Current Neurology and Neuroscience Reports.  15 (2014)  1 - p. , 2014
Link: https://doi.org/10.1007/..
 
1-15